Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Feb;3(1):145-52.
doi: 10.2147/nedt.2007.3.1.145.

Prodromal non-motor symptoms of Parkinson's disease

Affiliations

Prodromal non-motor symptoms of Parkinson's disease

Clelia Pellicano et al. Neuropsychiatr Dis Treat. 2007 Feb.

Abstract

The motor symptoms of Parkinson's disease (PD), bradykinesia, muscular rigidity, and tremor depend upon degeneration of the dopaminergic neurons in the substantia nigra pars compacta. Recent neuropathological studies show that the Lewy bodies, the intraneuronal landmark of PD, accumulate in several neuronal cell types in the brain. An ascending gradient of pathological involvement, from the medulla oblongata to neocortical areas has been reported. Thus the original view of PD as a disease characterized by selective damage of the dopaminergic neurons in the mesencephalon should be updated into the concept of a severe multisystemic neurodegenerative disorder. Additionally, the neuropathological alterations outside the substantia nigra are soundly correlated with the non-motor symptoms of PD. As a result of these findings, interest is growing in the identification of prodromal non-motor symptoms of PD. Indeed, data from the literature suggest that autonomic disturbances, olfactory dysfunctions, depression and sleep disorders (in particular REM-sleep behavior disorder) may represent prodromal non-motor symptoms of PD. Several tests are available to detect most of these symptoms. Thus, the identification of prodromal non-motor symptoms may contribute to the precocious diagnosis of PD, and might be useful in the future to test the efficacy of neuroprotective agents.

Keywords: Parkinson’s disease; RBD; autonomic dysfunction; depression; non-motor symptoms; olfactory dysfunction.

PubMed Disclaimer

References

    1. Abbott RD, Petrovitch H, White LR, et al. Frequency of bowel movements and the future risk of Parkinson’s disease. Neurology. 2001;57:456–62. - PubMed
    1. Abbott RD, Ross GW, White LR, et al. Excessive daytime sleepiness and subsequent development of Parkinson’s disease. Neurology. 2005;65:1442–6. - PubMed
    1. Abe T, Isobe C, Murata T, et al. Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson’s disease. Neurosci Lett. 2003;336:105–8. - PubMed
    1. Ansari KA, Johnson A. Olfactory dysfunction in patients with Parkinson’s disease. J Chronic Dis. 1975;28:493–7. - PubMed
    1. Bannister R, Mathias CJ. Clinical features and evaluation of primary chronic autonomic failure syndromes. In: Mathias CJ, Bannister R, editors. Autonomic failure. 4th ed . Oxford: Oxford Univ. Pr; 1999. pp. 307–16.